Literature DB >> 31151972

Miliary pattern on chest imaging as a presentation of EGFR-negative primary lung adenocarcinoma.

Seth A Hoffman1, Scott Manski1, Janaki Deepak2.   

Abstract

A 64-year-old African American man, with a history of prostate adenocarcinoma treated in 2009 and a greater than 50-pack-year tobacco smoking history, presented with 2-3 weeks of non-productive cough, frontal headache and generalised myalgias and arthralgias. CT was positive for diffuse, miliary opacities in bilateral lung fields. He was diagnosed with stage four lung adenocarcinoma, negative for epidermal growth factor receptor (EGFR) gene mutation. The patient was unable to tolerate therapy and passed away approximately 4 months after his diagnosis. Previous case reports and research have suggested an association between EGFR gene mutation and miliary patterned lung metastases in non-small cell lung cancer. This case suggests that the mechanism by which miliary patterned metastases occur is more complex than purely mutation of the EGFR gene. Further study may elucidate novel molecular targets for treatment, especially in patients with rapidly progressive disease such as the patient we describe. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  lung cancer (oncology); oncology; respiratory cancer; respiratory medicine; tobacco-related disease

Mesh:

Substances:

Year:  2019        PMID: 31151972      PMCID: PMC6557528          DOI: 10.1136/bcr-2018-228534

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Is a miliary chest pattern always indicative of tuberculosis or malignancy?

Authors:  Anastassios V Koutsopoulos; Ioanna Mitrouska; Konstantina I Dambaki; Argyro Voloudaki; Elpida Vardaki; Vrettos Haniotis; Ioannis A Drositis; Nikolaos M Siafakas; Efstathios N Stathopoulos
Journal:  Respiration       Date:  2006-01-27       Impact factor: 3.580

2.  Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.

Authors:  Corey J Langer; Shirish M Gadgeel; Hossein Borghaei; Vassiliki A Papadimitrakopoulou; Amita Patnaik; Steven F Powell; Ryan D Gentzler; Renato G Martins; James P Stevenson; Shadia I Jalal; Amit Panwalkar; James Chih-Hsin Yang; Matthew Gubens; Lecia V Sequist; Mark M Awad; Joseph Fiore; Yang Ge; Harry Raftopoulos; Leena Gandhi
Journal:  Lancet Oncol       Date:  2016-10-10       Impact factor: 41.316

3.  Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion.

Authors:  Eckart Laack; Ronald Simon; Marc Regier; Birte Andritzky; Pierre Tennstedt; Christian Habermann; Christoph Zur Verth; Ina Thöm; Tobias Grob; Guido Sauter; Carsten Bokemeyer
Journal:  J Thorac Oncol       Date:  2011-01       Impact factor: 15.609

4.  Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis.

Authors:  Shang-Gin Wu; Fu-Chang Hu; Yih-Leong Chang; Yung-Chie Lee; Chong-Jen Yu; Yeun-Chung Chang; Jenn-Yu Wu; Jin-Yuan Shih; Pan-Chyr Yang
Journal:  Eur Respir J       Date:  2012-04-20       Impact factor: 16.671

5.  Association of miliary lung metastases and bone metastases in bronchogenic carcinoma.

Authors:  S Umeki
Journal:  Chest       Date:  1993-09       Impact factor: 9.410

6.  [Hemorrhagic pericardial effusion and multiple pulmonary nodules in a 37 year old male who has "never smoked"].

Authors:  M Sebastian; A Schad; S Schadmand-Fischer; F Post; S Meier; E Springer; J Makowski; C Taube; R Wiewrodt; B Fischer; R Buhl
Journal:  Internist (Berl)       Date:  2009-01       Impact factor: 0.743

7.  A rare case of non-small cell carcinoma of lung presenting as miliary mottling.

Authors:  Ballaekere Jayaram Subhashchandra; Mohammed Ismailkhan; Kuppegala Chikkaveeraiah Shashidhar; Moda Gopalakrishna Narahari
Journal:  Iran J Med Sci       Date:  2013-03

8.  Clinical features of lung adenocarcinomas with epidermal growth factor receptor mutations and miliary disseminated carcinomatosis.

Authors:  Hee Joung Kim; Seong Hui Kang; Hyun Woo Chung; Jong Sik Lee; Sun Jong Kim; Kwang Ha Yoo; Kye Young Lee
Journal:  Thorac Cancer       Date:  2015-02-14       Impact factor: 3.500

  8 in total
  1 in total

1.  Imaging Pattern of Diffuse Intrapulmonary Metastases in Lung Cancer Was Associated with Poor Prognosis to Epidermal Growth Factor Receptor Inhibitors.

Authors:  Yang Fu; Yuan Tang; Yue Zheng; Yue-Yun Chen; Ye Hong; Pei-Pei Wang; Qing Li; Ting Liu; Zhen-Yu Ding
Journal:  Cancer Manag Res       Date:  2020-11-17       Impact factor: 3.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.